Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Amphetamine-induced activation of neurons within the rat nucleus of the solitary tract.

Edwards CM, Strother J, Zheng H, Rinaman L.

Physiol Behav. 2019 May 15;204:355-363. doi: 10.1016/j.physbeh.2019.02.040. Epub 2019 Mar 1.

PMID:
30831183
2.

G protein βγ subunits play a critical role in the actions of amphetamine.

Mauna JC, Harris SS, Pino JA, Edwards CM, DeChellis-Marks MR, Bassi CD, Garcia-Olivares J, Amara SG, Guajardo FG, Sotomayor-Zarate R, Terminel M, Castañeda E, Vergara M, Baust T, Thiels E, Torres GE.

Transl Psychiatry. 2019 Feb 11;9(1):81. doi: 10.1038/s41398-019-0387-8.

3.

Animal Models of Multiple Myeloma.

Olechnowicz SWZ, Edwards CM.

Methods Mol Biol. 2019;1914:349-360. doi: 10.1007/978-1-4939-8997-3_20.

PMID:
30729476
4.

STATISTICAL COMPARISON OF AFIRMA GSC AND AFIRMA GEC OUTCOMES IN A COMMUNITY ENDOCRINE SURGICAL PRACTICE: EARLY FINDINGS.

Harrell RM, Eyerly-Webb SA, Golding AC, Edwards CM, Bimston DN.

Endocr Pract. 2019 Feb;25(2):161-164. doi: 10.4158/EP-2018-0395. Epub 2018 Nov 1.

PMID:
30383497
5.

Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis.

Gámez B, Edwards CM.

Curr Osteoporos Rep. 2018 Dec;16(6):635-641. doi: 10.1007/s11914-018-0479-z. Review.

6.

Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma.

Morris EV, Edwards CM.

J Cell Physiol. 2018 Dec;233(12):9159-9166. doi: 10.1002/jcp.26884. Epub 2018 Jun 26. Review.

PMID:
29943829
7.

COMMUNITY ENDOCRINE SURGICAL EXPERIENCE WITH FALSE-NEGATIVE AFIRMA GEC® RESULTS: 2011-2017.

Harrell RM, Eyerly-Webb SA, Pinnar NE, Golding AC, Edwards CM, Bimston DN.

Endocr Pract. 2018 Jul;24(7):622-627. doi: 10.4158/EP-2017-0263. Epub 2018 Apr 24.

PMID:
29688761
8.

Bone marrow adiposity and multiple myeloma.

Morris EV, Edwards CM.

Bone. 2019 Jan;118:42-46. doi: 10.1016/j.bone.2018.03.011. Epub 2018 Mar 13.

PMID:
29548987
9.

Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats.

Kirschmann EK, McCalley DM, Edwards CM, Torregrossa MM.

Front Behav Neurosci. 2017 Jul 21;11:137. doi: 10.3389/fnbeh.2017.00137. eCollection 2017.

10.

Metformin and Prostate Cancer: a New Role for an Old Drug.

Whitburn J, Edwards CM, Sooriakumaran P.

Curr Urol Rep. 2017 Jun;18(6):46. doi: 10.1007/s11934-017-0693-8. Review.

11.

A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.

Lwin ST, Fowler JA, Drake MT, Edwards JR, Lynch CC, Edwards CM.

Mol Cancer. 2017 Feb 28;16(1):49. doi: 10.1186/s12943-017-0616-9.

12.

Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer.

Rao SR, Snaith AE, Marino D, Cheng X, Lwin ST, Orriss IR, Hamdy FC, Edwards CM.

Br J Cancer. 2017 Jan 17;116(2):227-236. doi: 10.1038/bjc.2016.402. Epub 2016 Dec 22.

13.

Prediabetes: A Worldwide Epidemic.

Edwards CM, Cusi K.

Endocrinol Metab Clin North Am. 2016 Dec;45(4):751-764. doi: 10.1016/j.ecl.2016.06.007. Epub 2016 Oct 2. Review.

PMID:
27823603
14.

Central venous parathyroid hormone monitoring using a novel, specific anatomic method accurately predicts cure during minimally invasive parathyroidectomy.

Edwards CM, Folek J, Dayawansa S, Govednik CM, Quinn CE, Sigmond BR, Lee CY, Angel MS, Hendricks JC, Lairmore TC.

Am J Surg. 2016 Dec;212(6):1154-1161. doi: 10.1016/j.amjsurg.2016.09.015. Epub 2016 Sep 30.

PMID:
27793324
15.

The role of bone marrow adipocytes in bone metastasis.

Morris EV, Edwards CM.

J Bone Oncol. 2016 Apr 8;5(3):121-123. eCollection 2016 Sep.

16.

The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.

Turner CJ, Edwards CM.

Curr Osteoporos Rep. 2016 Oct;14(5):170-7. doi: 10.1007/s11914-016-0323-2. Review.

PMID:
27566487
17.

Bone Marrow Adipose Tissue: A New Player in Cancer Metastasis to Bone.

Morris EV, Edwards CM.

Front Endocrinol (Lausanne). 2016 Jul 14;7:90. doi: 10.3389/fendo.2016.00090. eCollection 2016. Review.

18.

New approaches to targeting the bone marrow microenvironment in multiple myeloma.

Gooding S, Edwards CM.

Curr Opin Pharmacol. 2016 Jun;28:43-9. doi: 10.1016/j.coph.2016.02.013. Epub 2016 Mar 23. Review.

PMID:
27018230
19.

Preclinical animal models of multiple myeloma.

Lwin ST, Edwards CM, Silbermann R.

Bonekey Rep. 2016 Feb 3;5:772. doi: 10.1038/bonekey.2015.142. eCollection 2016.

20.

5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma.

Cheng JP, Leary JB, Sembhi A, Edwards CM, Bondi CO, Kline AE.

Brain Res. 2016 Jun 1;1640(Pt A):5-14. doi: 10.1016/j.brainres.2015.11.026. Epub 2015 Nov 21. Review.

21.

A hairy fall: syncope resulting from topical application of minoxidil.

Dubrey SW, VanGriethuysen J, Edwards CM.

BMJ Case Rep. 2015 Sep 7;2015. pii: bcr2015210945. doi: 10.1136/bcr-2015-210945.

22.

Visual Priming Enhances the Effects of Nonspatial Cognitive Rehabilitation Training on Spatial Learning After Experimental Traumatic Brain Injury.

Edwards CM, Kumar K, Koesarie K, Brough E, Ritter AC, Brayer SW, Thiels E, Skidmore ER, Wagner AK.

Neurorehabil Neural Repair. 2015 Oct;29(9):897-906. doi: 10.1177/1545968315570326. Epub 2015 Feb 9.

23.

Diet-induced obesity promotes a myeloma-like condition in vivo.

Lwin ST, Olechnowicz SW, Fowler JA, Edwards CM.

Leukemia. 2015 Feb;29(2):507-10. doi: 10.1038/leu.2014.295. Epub 2014 Oct 7. No abstract available.

PMID:
25287992
24.

Novel therapeutic targets in myeloma bone disease.

Webb SL, Edwards CM.

Br J Pharmacol. 2014 Aug;171(16):3765-76. doi: 10.1111/bph.12742. Review.

25.

Differences in age-related effects on brain volume in Down syndrome as compared to Williams syndrome and typical development.

Koran ME, Hohman TJ, Edwards CM, Vega JN, Pryweller JR, Slosky LE, Crockett G, Villa de Rey L, Meda SA, Dankner N, Avery SN, Blackford JU, Dykens EM, Thornton-Wells TA.

J Neurodev Disord. 2014;6(1):8. doi: 10.1186/1866-1955-6-8. Epub 2014 Apr 9.

26.

Contributions of the host microenvironment to cancer-induced bone disease.

Olechnowicz SW, Edwards CM.

Cancer Res. 2014 Mar 15;74(6):1625-31. doi: 10.1158/0008-5472.CAN-13-2645. Epub 2014 Mar 5. Review.

27.

Triglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stress.

Wang YI, Bettaieb A, Sun C, DeVerse JS, Radecke CE, Mathew S, Edwards CM, Haj FG, Passerini AG, Simon SI.

PLoS One. 2013 Oct 21;8(10):e78322. doi: 10.1371/journal.pone.0078322. eCollection 2013.

28.

Shear stress modulates VCAM-1 expression in response to TNF-α and dietary lipids via interferon regulatory factor-1 in cultured endothelium.

DeVerse JS, Sandhu AS, Mendoza N, Edwards CM, Sun C, Simon SI, Passerini AG.

Am J Physiol Heart Circ Physiol. 2013 Oct 15;305(8):H1149-57. doi: 10.1152/ajpheart.00311.2013. Epub 2013 Aug 9.

29.

Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes.

Edwards CM.

Br J Hosp Med (Lond). 2013 Apr;74(4):198-201. Review. No abstract available.

PMID:
23571389
30.

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.

Zhuang J, Zhang J, Lwin ST, Edwards JR, Edwards CM, Mundy GR, Yang X.

PLoS One. 2012;7(11):e48871. doi: 10.1371/journal.pone.0048871. Epub 2012 Nov 16.

31.

BTK inhibition in myeloma: targeting the seed and the soil.

Edwards CM.

Blood. 2012 Aug 30;120(9):1757-9. doi: 10.1182/blood-2012-07-439216. No abstract available.

32.

IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal.

Sun C, Alkhoury K, Wang YI, Foster GA, Radecke CE, Tam K, Edwards CM, Facciotti MT, Armstrong EJ, Knowlton AA, Newman JW, Passerini AG, Simon SI.

Circ Res. 2012 Sep 28;111(8):1054-64. Epub 2012 Aug 8.

33.

Classifying general nonlinear force laws in cell-based models via the continuum limit.

Murray PJ, Edwards CM, Tindall MJ, Maini PK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Feb;85(2 Pt 1):021921. Epub 2012 Feb 23.

PMID:
22463258
34.

Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.

Fowler JA, Mundy GR, Lwin ST, Edwards CM.

Cancer Res. 2012 May 1;72(9):2183-9. doi: 10.1158/0008-5472.CAN-11-2067. Epub 2012 Feb 28.

35.

Force localization in contracting cell layers.

Edwards CM, Schwarz US.

Phys Rev Lett. 2011 Sep 16;107(12):128101. Epub 2011 Sep 15.

PMID:
22026803
36.

Dynamic ordering of nuclei in syncytial embryos: a quantitative analysis of the role of cytoskeletal networks.

Kanesaki T, Edwards CM, Schwarz US, Grosshans J.

Integr Biol (Camb). 2011 Nov;3(11):1112-9. doi: 10.1039/c1ib00059d. Epub 2011 Oct 14.

PMID:
22001900
37.

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.

Fowler JA, Lwin ST, Drake MT, Edwards JR, Kyle RA, Mundy GR, Edwards CM.

Blood. 2011 Nov 24;118(22):5872-82. doi: 10.1182/blood-2011-01-330407. Epub 2011 Sep 8.

38.

Renal impairment with sitagliptin: is there a need for active monitoring of potential renal toxicity?

Lestner JM, Baburaj R, Edwards CM.

Br J Hosp Med (Lond). 2011 Jul;72(7):412-3. No abstract available.

PMID:
21841617
39.

Comparing a discrete and continuum model of the intestinal crypt.

Murray PJ, Walter A, Fletcher AG, Edwards CM, Tindall MJ, Maini PK.

Phys Biol. 2011 Apr;8(2):026011. doi: 10.1088/1478-3975/8/2/026011. Epub 2011 Mar 16.

40.

A United Kingdom inflammatory bowel disease database: making the effort worthwhile.

Bardhan KD, Simmonds N, Royston C, Dhar A, Edwards CM; Rotherham IBD Database Users Group.

J Crohns Colitis. 2010 Oct;4(4):405-12. doi: 10.1016/j.crohns.2010.01.003. Epub 2010 Feb 19.

PMID:
21122536
41.

On the proportion of cancer stem cells in a tumour.

Johnston MD, Maini PK, Jonathan Chapman S, Edwards CM, Bodmer WF.

J Theor Biol. 2010 Oct 21;266(4):708-11. doi: 10.1016/j.jtbi.2010.07.031. Epub 2010 Aug 3.

PMID:
20678505
42.

Tumor-host cell interactions in the bone disease of myeloma.

Fowler JA, Edwards CM, Croucher PI.

Bone. 2011 Jan;48(1):121-8. doi: 10.1016/j.bone.2010.06.029. Epub 2010 Jul 13. Review.

43.

Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis.

Yang L, Edwards CM, Mundy GR.

J Bone Miner Res. 2010 Aug;25(8):1701-6. doi: 10.1002/jbmr.154.

44.

Appendiceal adenocarcinoma presenting as venous thromboembolism: an unusual presentation of a rare carcinoma.

Castellanos JA, Edwards CM, Shaver A, Merchant NB, Parikh AA.

Am Surg. 2010 May;76(5):543-4. No abstract available.

45.

A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease.

Ayati BP, Edwards CM, Webb GF, Wikswo JP.

Biol Direct. 2010 Apr 20;5:28. doi: 10.1186/1745-6150-5-28.

46.

From a discrete to a continuum model of cell dynamics in one dimension.

Murray PJ, Edwards CM, Tindall MJ, Maini PK.

Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Sep;80(3 Pt 1):031912. Epub 2009 Sep 23.

PMID:
19905151
47.

A murine model of myeloma that allows genetic manipulation of the host microenvironment.

Fowler JA, Mundy GR, Lwin ST, Lynch CC, Edwards CM.

Dis Model Mech. 2009 Nov-Dec;2(11-12):604-11. doi: 10.1242/dmm.003160. Epub 2009 Sep 24.

48.

Takotsubo cardiomyopathy presenting with dyspnea.

Pezzo SP, Hartlage G, Edwards CM.

J Hosp Med. 2009 Mar;4(3):200-2. doi: 10.1002/jhm.402.

PMID:
19301382
49.

Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.

Edwards CM, Lwin ST, Fowler JA, Oyajobi BO, Zhuang J, Bates AL, Mundy GR.

Am J Hematol. 2009 May;84(5):268-72. doi: 10.1002/ajh.21374.

50.

Eph receptors and ephrin signaling pathways: a role in bone homeostasis.

Edwards CM, Mundy GR.

Int J Med Sci. 2008 Sep 3;5(5):263-72. Review.

Supplemental Content

Loading ...
Support Center